Flexeril and Cataflam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Cataflam (diclofenac potassium). Common drug interactions include bile duct stone among females and amnesia among males.

The phase IV clinical study analyzes what interactions people have when they take Flexeril and Cataflam. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.

What is Cataflam?

Cataflam has active ingredients of diclofenac potassium. It is often used in pain. eHealthMe is studying from 1,851 Cataflam users. Check the latest studies of Cataflam.



On Jul, 14, 2026

54 people who take Flexeril and Cataflam together, and have interactions are studied.

Flexeril and Cataflam drug interactions.

What are the common drug interactions of Flexeril and Cataflam, by gender? *:

female:

  1. Bile duct stone
  2. Biliary dilatation
  3. Bleeding anovulatory
  4. Blood chloride increased
  5. Blood glucose decreased
  6. Blood glucose increased
  7. Blood pressure decreased
  8. Blood urine present
  9. Brain neoplasm (tumour of brain)
  10. Burning sensation

male:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Asthenia (weakness)
  3. Oedema peripheral (superficial swelling)
  4. Decreased appetite
  5. Dizziness
  6. Drug ineffective
  7. Dysstasia (difficulty in standing)
  8. Feeling drunk
  9. Gait disturbance
  10. Hepatitis (inflammation of the liver)

What are the common drug interactions of Flexeril and Cataflam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Cholecystitis chronic (long lasting infection of gallbladder)
  4. Depression
  5. Emotional distress
  6. Gallbladder disorder
  7. Gallbladder pain
  8. General physical health deterioration (weak health status)
  9. Injury
  10. Migraine (headache)

30-39:

  1. Abdominal pain
  2. Aphasia (damage to the parts of the brain that control language)
  3. Blood chloride increased
  4. Blood urine present
  5. Calculus urinary (stone in urinary system)
  6. Carbon dioxide decreased
  7. Depression
  8. Drug ineffective
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Emotional disorder

40-49:

  1. Appendicitis (inflammation of the appendix)
  2. Bedridden
  3. Hyperhidrosis (abnormally increased sweating)
  4. Hypersensitivity
  5. Platelet count decreased
  6. White blood cell count decreased
  7. Activities of daily living impaired
  8. Adjustment disorder with depressed mood
  9. Asthenia (weakness)
  10. Biliary dilatation

50-59:

  1. Haemoglobin decreased
  2. Hypersensitivity
  3. Hypertension (high blood pressure)
  4. Inflammation
  5. Injection site bruising
  6. Injection site pain
  7. Injury
  8. Limb injury
  9. Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
  10. Malaise (a feeling of general discomfort or uneasiness)

60+:

  1. Confusional state
  2. Hepatitis (inflammation of the liver)
  3. Drug hypersensitivity
  4. Dysarthria (speech disorder)
  5. Dyspnoea (difficult or laboured respiration)
  6. Escherichia sepsis (bacterial infection by escherichia coli)
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Hypotension (abnormally low blood pressure)
  9. Oedema peripheral (superficial swelling)
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 13 people, 24.07%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 14.81%
  3. High Blood Pressure: 7 people, 12.96%
  4. Insomnia (sleeplessness): 5 people, 9.26%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 7.41%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 7.41%
  7. Depression: 4 people, 7.41%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 7.41%
  9. Temporomandibular Joint Syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress): 3 people, 5.56%
  10. Skin Wrinkling (wrinkle on skin): 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and Cataflam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flexeril and Cataflam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cataflam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cataflam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and diclofenac potassium (the active ingredients of Flexeril and Cataflam, respectively), and Flexeril and Cataflam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: